Serenex
Drug discovery and development company that is focused on oncology.
Launch date
Employees
Market cap
-
Enterprise valuation
$104—156m (Dealroom.co estimates Jun 2007.)
Durham North Carolina (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
$2.0m | Series A | ||
$15.0m | Series B | ||
$8.0m | Early VC | ||
$30.0m | Series C | ||
$26.0m | Series D | ||
N/A | Acquisition | ||
Total Funding | $81.0m |
Recent News about Serenex
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.